AbCellera Biologics Inc. ABCL Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s effective income tax rate reconciliation, tax credit, research, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s effective income tax rate reconciliation, tax credit, research, amount?
- AbCellera Biologics Inc. (ABCL) reported effective income tax rate reconciliation, tax credit, research, amount of $1.5M in Q4 2025.
- How has AbCellera Biologics Inc.'s effective income tax rate reconciliation, tax credit, research, amount changed year-over-year?
- AbCellera Biologics Inc.'s effective income tax rate reconciliation, tax credit, research, amount decreased by 27.0% year-over-year, from $2.06M to $1.5M.
- What is the long-term trend for AbCellera Biologics Inc.'s effective income tax rate reconciliation, tax credit, research, amount?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s effective income tax rate reconciliation, tax credit, research, amount has grown at a -10.1% compound annual growth rate (CAGR), from $7.43M to $6M.
- What does effective income tax rate reconciliation, tax credit, research, amount mean?
- Quantifies the dollar amount of research and development tax credits that reduce the company's total income tax provision. This metric is a key indicator of the tax benefits realized from the company's investment in innovation and R&D activities.